BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 31720814)

  • 41. PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model.
    Tzeng HT; Tsai HF; Liao HJ; Lin YJ; Chen L; Chen PJ; Hsu PN
    PLoS One; 2012; 7(6):e39179. PubMed ID: 22761734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.
    Chauvin JM; Pagliano O; Fourcade J; Sun Z; Wang H; Sander C; Kirkwood JM; Chen TH; Maurer M; Korman AJ; Zarour HM
    J Clin Invest; 2015 May; 125(5):2046-58. PubMed ID: 25866972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro.
    Rossi M; Vecchi A; Tiezzi C; Barili V; Fisicaro P; Penna A; Montali I; Daffis S; Fletcher SP; Gaggar A; Medley J; Graupe M; Lad L; Loglio A; Soffredini R; Borghi M; Pollicino T; Musolino C; Alfieri A; Brillo F; Laccabue D; Massari M; Boarini C; Abbati G; Pedrazzi G; Missale G; Lampertico P; Ferrari C; Boni C
    Gut; 2023 Nov; 72(11):2123-2137. PubMed ID: 36717219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia.
    Zhu L; Kong Y; Zhang J; Claxton DF; Ehmann WC; Rybka WB; Palmisiano ND; Wang M; Jia B; Bayerl M; Schell TD; Hohl RJ; Zeng H; Zheng H
    J Hematol Oncol; 2017 Jun; 10(1):124. PubMed ID: 28629373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation.
    Itoh S; Yoshizumi T; Yugawa K; Imai D; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Soejima Y; Kohashi K; Oda Y; Mori M
    Hepatology; 2020 Dec; 72(6):1987-1999. PubMed ID: 32112577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection.
    Gu S; Fu X; Ye G; Chen C; Li X; Zhong S; Tang L; Chen H; Jiang D; Hou J; Li Y
    Front Immunol; 2021; 12():649197. PubMed ID: 34234772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients.
    Zhang Z; Jin B; Zhang JY; Xu B; Wang H; Shi M; Wherry EJ; Lau GK; Wang FS
    J Hepatol; 2009 Jun; 50(6):1163-73. PubMed ID: 19395117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD40 activation rescues antiviral CD8⁺ T cells from PD-1-mediated exhaustion.
    Isogawa M; Chung J; Murata Y; Kakimi K; Chisari FV
    PLoS Pathog; 2013; 9(7):e1003490. PubMed ID: 23853599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8
    Kim HD; Park S; Jeong S; Lee YJ; Lee H; Kim CG; Kim KH; Hong SM; Lee JY; Kim S; Kim HK; Min BS; Chang JH; Ju YS; Shin EC; Song GW; Hwang S; Park SH
    Hepatology; 2020 Mar; 71(3):955-971. PubMed ID: 31353502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.
    Shi F; Shi M; Zeng Z; Qi RZ; Liu ZW; Zhang JY; Yang YP; Tien P; Wang FS
    Int J Cancer; 2011 Feb; 128(4):887-96. PubMed ID: 20473887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular Recalibration of PD-1+ Antigen-Specific T Cells from Blood and Liver.
    Otano I; Escors D; Schurich A; Singh H; Robertson F; Davidson BR; Fusai G; Vargas FA; Tan ZMD; Aw JYJ; Hansi N; Kennedy PTF; Xue SA; Stauss HJ; Bertoletti A; Pavesi A; Maini MK
    Mol Ther; 2018 Nov; 26(11):2553-2566. PubMed ID: 30217730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T-cell Immunoglobulin and ITIM Domain Contributes to CD8
    Song Y; Wang B; Song R; Hao Y; Wang D; Li Y; Jiang Y; Xu L; Ma Y; Zheng H; Kong Y; Zeng H
    Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29349889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
    Shi X; Li CW; Tan LC; Wen SS; Liao T; Zhang Y; Chen TZ; Ma B; Yu PC; Lu ZW; Qu N; Wang Y; Shi RL; Wang YL; Ji QH; Wei WJ
    J Clin Endocrinol Metab; 2021 Jan; 106(1):120-132. PubMed ID: 33000173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma.
    Langhans B; Nischalke HD; Krämer B; Dold L; Lutz P; Mohr R; Vogt A; Toma M; Eis-Hübinger AM; Nattermann J; Strassburg CP; Gonzalez-Carmona MA; Spengler U
    Cancer Immunol Immunother; 2019 Dec; 68(12):2055-2066. PubMed ID: 31724091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.
    Raziorrouh B; Schraut W; Gerlach T; Nowack D; Grüner NH; Ulsenheimer A; Zachoval R; Wächtler M; Spannagl M; Haas J; Diepolder HM; Jung MC
    Hepatology; 2010 Dec; 52(6):1934-47. PubMed ID: 21064032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and clinical relevance of T-helper cells, Th17 and Th1, in hepatitis B virus-related hepatocellular carcinoma.
    Yan J; Liu XL; Xiao G; Li NL; Deng YN; Han LZ; Yin LC; Ling LJ; Liu LX
    PLoS One; 2014; 9(5):e96080. PubMed ID: 24867183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes.
    Lee WJ; Lee YJ; Choi ME; Yun KA; Won CH; Lee MW; Choi JH; Chang SE
    J Am Acad Dermatol; 2019 Jul; 81(1):219-227. PubMed ID: 30880064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8
    Rong Y; Dong Z; Hong Z; Jin Y; Zhang W; Zhang B; Mao W; Kong H; Wang C; Yang B; Gao X; Song Z; Green SE; Song HK; Wang H; Lu Y
    Exp Cell Res; 2017 Sep; 358(2):352-359. PubMed ID: 28694023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8
    Meyiah A; Mahmoodi Chalbatani G; Al-Mterin MA; Malekraeisi MA; Murshed K; Elkord E
    Int Immunopharmacol; 2023 Jun; 119():110207. PubMed ID: 37099940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The transcription factor Eomes promotes expression of inhibitory receptors on hepatic CD8
    Yu L; Guan Y; Li L; Lu N; Zhang C
    FEBS J; 2022 Jun; 289(11):3241-3261. PubMed ID: 34986510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.